Market Research

North America Pharmaceutical Suspension Market Size, Share & Trends Analysis Report By Type, By Distribution Channel, By End User, By Indication (Cancer, Neurological, Infectious Diseases, Gastrointestinal, and Others), By Country and Growth Forecast, 202

Best Price Guarantee Length Publisher Published Date SKU
from $1,500 133 Pages Knowledge Based Value (KBV) Research February, 2024 KBV18592732
Best Price Guarantee
Price from $1,500
Length 133 Pages
Publisher Knowledge Based Value (KBV) Research
Published Date February, 2024
SKU KBV18592732

North America Pharmaceutical Suspension Market Size, Share & Trends Analysis Report By Type, By Distribution Channel, By End User, By Indication (Cancer, Neurological, Infectious Diseases, Gastrointestinal, and Others), By Country and Growth Forecast, 2023 - 2030


The North America Pharmaceutical Suspension Market would witness market growth of 3.3% CAGR during the forecast period (2023-2030).

Pharmaceutical suspensions are extensively used in pediatric medicine, addressing the challenge of administering medications to children with difficulty swallowing tablets or capsules. Liquid suspensions offer a palatable and easily swallowable alternative, ensuring accurate dosing for pediatric patients. Elderly individuals often face challenges associated with swallowing solid dosage forms. Pharmaceutical suspensions provide a convenient solution for geriatric patients who may experience difficulties in medication administration. This use enhances patient compliance and ensures elderly individuals receive their medications effectively.

Pharmaceutical suspensions are employed to improve the bioavailability of drugs with poor solubility. Converting poorly soluble compounds into suspensions increases the surface area for absorption, enhancing therapeutic efficacy. This application is crucial for drugs with low bioavailability that may otherwise exhibit suboptimal clinical outcomes. Taste masking is a significant application of pharmaceutical suspensions, particularly in pediatric formulations. Many drugs have unpleasant tastes that can be a barrier to medication adherence, especially in children. Suspending such drugs in a liquid form allows for the addition of flavoring agents, making the medication more palatable and increasing patient acceptance.

Cancer treatment often involves personalized medicine, and pharmaceutical suspensions in Canada allow customized formulations tailored to individual patient needs. The liquid nature of pharmaceutical suspensions allows for targeted drug delivery to specific tumour sites in Canada. This precision in drug delivery can enhance the therapeutic effect while minimizing side effects on healthy tissues in Canada. Hence, the factors mentioned above will drive the regional market growth.

The US market dominated the North America Pharmaceutical Suspension Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $18,546 million by 2030. The Canada market is experiencing a CAGR of 5.6% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 4.7% during (2023 - 2030).

Based on Type, the market is segmented into Parenteral, Oral, and Others. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies, and Online Providers. Based on End User, the market is segmented into Hospitals and Clinics, Home Care Settings, and Others. Based on Indication, the market is segmented into Cancer, Neurological, Infectious Diseases, Gastrointestinal, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled
  • Merck & Co., Inc.
  • Bayer AG
  • Sanofi S.A.
  • Pfizer, Inc.
  • Novartis AG
  • AstraZeneca PLC
  • Glenmark Pharmaceuticals Limited
  • Teva Pharmaceutical Industries Ltd.
  • Eli Lilly And Company
  • Lupin Limited
North America Pharmaceutical Suspension Market Report Segmentation

By Type
  • Parenteral
  • Oral
  • Others
By Distribution Channel
  • Drug Store & Retail Pharmacies
  • Hospital Pharmacies
  • Online Providers
By End User
  • Hospitals and Clinics
  • Home Care Settings
  • Others
By Indication
  • Cancer
  • Neurological
  • Infectious Diseases
  • Gastrointestinal
  • Others
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Pharmaceutical Suspension Market, by Type
1.4.2 North America Pharmaceutical Suspension Market, by Distribution Channel
1.4.3 North America Pharmaceutical Suspension Market, by End User
1.4.4 North America Pharmaceutical Suspension Market, by Indication
1.4.5 North America Pharmaceutical Suspension Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Strategies Deployed in Pharmaceutical Suspension Market
Chapter 5. North America Pharmaceutical Suspension Market by Type
5.1 North America Parenteral Market by Country
5.2 North America Oral Market by Country
5.3 North America Others Market by Country
Chapter 6. North America Pharmaceutical Suspension Market by Distribution Channel
6.1 North America Drug Store & Retail Pharmacies Market by Country
6.2 North America Hospital Pharmacies Market by Country
6.3 North America Online Providers Market by Country
Chapter 7. North America Pharmaceutical Suspension Market by End User
7.1 North America Hospitals and Clinics Market by Country
7.2 North America Home Care Settings Market by Country
7.3 North America Others Market by Country
Chapter 8. North America Pharmaceutical Suspension Market by Indication
8.1 North America Cancer Market by Country
8.2 North America Neurological Market by Country
8.3 North America Infectious Diseases Market by Country
8.4 North America Gastrointestinal Market by Country
8.5 North America Others Market by Country
Chapter 9. North America Pharmaceutical Suspension Market by Country
9.1 US Pharmaceutical Suspension Market
9.1.1 US Pharmaceutical Suspension Market by Type
9.1.2 US Pharmaceutical Suspension Market by Distribution Channel
9.1.3 US Pharmaceutical Suspension Market by End User
9.1.4 US Pharmaceutical Suspension Market by Indication
9.2 Canada Pharmaceutical Suspension Market
9.2.1 Canada Pharmaceutical Suspension Market by Type
9.2.2 Canada Pharmaceutical Suspension Market by Distribution Channel
9.2.3 Canada Pharmaceutical Suspension Market by End User
9.2.4 Canada Pharmaceutical Suspension Market by Indication
9.3 Mexico Pharmaceutical Suspension Market
9.3.1 Mexico Pharmaceutical Suspension Market by Type
9.3.2 Mexico Pharmaceutical Suspension Market by Distribution Channel
9.3.3 Mexico Pharmaceutical Suspension Market by End User
9.3.4 Mexico Pharmaceutical Suspension Market by Indication
9.4 Rest of North America Pharmaceutical Suspension Market
9.4.1 Rest of North America Pharmaceutical Suspension Market by Type
9.4.2 Rest of North America Pharmaceutical Suspension Market by Distribution Channel
9.4.3 Rest of North America Pharmaceutical Suspension Market by End User
9.4.4 Rest of North America Pharmaceutical Suspension Market by Indication
Chapter 10. Company Profiles
10.1 Merck & Co., Inc.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expenses
10.1.5 SWOT Analysis
10.2 Bayer AG
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Product Launches and Product Expansions:
10.2.6 SWOT Analysis
10.3 Sanofi S.A.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expense
10.3.5 SWOT Analysis
10.4 Pfizer, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Regional & Segmental Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Acquisition and Mergers:
10.4.6 SWOT Analysis
10.5 Novartis AG
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expense
10.5.5 SWOT Analysis
10.6 AstraZeneca PLC
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Regional Analysis
10.6.4 Research & Development Expenses
10.6.5 Recent strategies and developments:
10.6.5.1 Acquisition and Mergers:
10.6.6 SWOT Analysis
10.7 Glenmark Pharmaceuticals Limited
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Regional Analysis
10.7.4 Research & Development Expenses
10.7.5 SWOT Analysis
10.8 Teva Pharmaceutical Industries Ltd.
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Regional Analysis
10.8.4 Research & Development Expenses
10.8.5 Recent strategies and developments:
10.8.5.1 Product Launches and Product Expansions:
10.8.6 SWOT Analysis
10.9 Eli Lilly And Company
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Regional Analysis
10.9.4 Research & Development Expenses
10.9.5 Recent strategies and developments:
10.9.5.1 Partnerships, Collaborations, and Agreements:
10.9.6 SWOT Analysis
10.10. Lupin Limited
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Regional Analysis
10.10.4 Research & Development Expense
10.10.5 Recent strategies and developments:
10.10.5.1 Partnerships, Collaborations, and Agreements:
10.10.5.2 Trials and Approvals:
10.10.6 SWOT Analysis

$1,500
$1,800
$2,520

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings